Quest Diagnostics (DGX) , in collaboration with the University of Alabama, conducted a study that suggests adherence to guideline-based laboratory testing and treatment of pregnant women for two of the most prevalent sexually transmitted infections (STIs) is suboptimal in the United States. This could potentially result in dire effects on maternal and newborn health. The study, titled "Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations", was published in the p ...